...
首页> 外文期刊>Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis >Mesenchymal stromal cells as multifunctional cellular therapeutics - a potential role for extracellular vesicles
【24h】

Mesenchymal stromal cells as multifunctional cellular therapeutics - a potential role for extracellular vesicles

机译:间充质基质细胞作为多功能细胞疗法-细胞外囊泡的潜在作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mesenchymal stromal cells (MSCs), multipotent cells present in tissues throughout the body, can reconstitute adipogenic, osteogenic and chondrogenic tissues, but are also of great interest as mediators of immune modulation and suppression. MSCs are able to improve transplant engraftment, treat graft versus host disease and suppress T cell responses and therefore have great potential as therapeutic agents. Their immune modulatory capacity is mediated through both cell-to-cell contact and cytokine secretion, but it is becoming clear that extracellular vesicles (EV) produced by MSC also possess immunomodulatory properties. These vesicles are easy to prepare and store, do not carry nuclear material and cannot form tumours, and therefore also represent a highly desirable therapeutic agent. This review outlines the formation and characterisation of extracellular vesicles, the reported function of MSC-EVs in vitro and in vivo, and addresses some of the emerging issues with nomenclature, EV therapeutic dose and tissue source. The development of GMP-grade production protocols and effective characterisation of MSC extracellular vesicles is essential to their successful use as immune modulating therapeutic agents, and this review outlines the current status of the research in this area. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.
机译:间充质基质细胞(MSCs)是存在于整个人体组织中的多能细胞,可以重组脂肪形成,成骨和成软骨组织,但作为免疫调节和抑制的介质也引起了极大的兴趣。 MSC能够改善移植物植入,治疗移植物抗宿主病并抑制T细胞反应,因此具有巨大的治疗潜力。它们的免疫调节能力是通过细胞间接触和细胞因子的分泌介导的,但是越来越清楚的是,由MSC产生的细胞外囊泡(EV)也具有免疫调节特性。这些囊泡易于制备和储存,不携带核物质并且不能形成肿瘤,因此也代表了非常理想的治疗剂。这篇综述概述了细胞外囊泡的形成和特征,已报道的MSC-EVs在体外和体内的功能,并解决了命名,EV治疗剂量和组织来源方面的一些新兴问题。 GMP级生产协议的开发和MSC细胞外囊泡的有效表征对于将其成功用作免疫调节治疗剂至关重要,本综述概述了该领域的研究现状。 Crown版权所有(C)2016,由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号